ACS chemical neuroscience molecule spotlight on Suvorexant - Wikidata - awgldk - TriplyDB

ACS chemical neuroscience molecule spotlight on Suvorexant

ACS chemical neuroscience molecule spotlight on Suvorexant

http://www.wikidata.org/entity/Q27026233

about

Discovery of 5''-chloro-N-[(5,6-dimethoxypyridin-2-yl)methyl]-2,2':5',3''-terpyridine-3'-carboxamide (MK-1064): a selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia Effects of a newly developed potent orexin-2 receptor-selective antagonist, compound 1 m, on sleep/wakefulness states in mice Suvorexant: something new for sleep?Synthesis of chiral aliphatic amines through asymmetric hydrogenation.

P2860

Q28304842-FB49BF2B-6EFC-4F90-BA59-B426534A0151 Q30570222-DF9F2990-CB5A-4139-88E1-83554E21D239 Q42703622-1B3E0A84-5961-422B-8BEA-0938E43915C4 Q43728810-FB841822-8B8E-4206-823C-E17724E5932E

P2860

ACS chemical neuroscience molecule spotlight on Suvorexant

http://www.wikidata.org/entity/Q27026233

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

ACS chemical neuroscience molecule spotlight on Suvorexant

@ast

ACS chemical neuroscience molecule spotlight on Suvorexant

@en

ACS chemical neuroscience molecule spotlight on Suvorexant

@nl

type

label

ACS chemical neuroscience molecule spotlight on Suvorexant

@ast

ACS chemical neuroscience molecule spotlight on Suvorexant

@en

ACS chemical neuroscience molecule spotlight on Suvorexant

@nl

prefLabel

ACS chemical neuroscience molecule spotlight on Suvorexant

@ast

ACS chemical neuroscience molecule spotlight on Suvorexant

@en

ACS chemical neuroscience molecule spotlight on Suvorexant

@nl

P1433

Q27026233-F22E6974-72AC-4BBC-9158-828C5983F808

P1476

Q27026233-D5C0E3AD-E6A6-4826-B096-DA7D5A475A25

P2093

Q27026233-6342D227-FC69-467F-8C55-99D7DB1042B9

P2860

Q27026233-232AF9B4-0E03-4B77-9683-BBC838B65AC7

Q27026233-28C860BC-7334-4968-A95E-DD2561010A61

Q27026233-736B577D-1AAD-4701-B768-0B6F74B04BE6

Q27026233-86D26109-EAD0-4E4B-97BD-0DA3DA226CA3

P304

Q27026233-3DFEBAC5-2DF5-4C99-8EFF-1137BF97D086

P31

Q27026233-1ea50d4d-a01e-4cf2-bbaf-483728d99a46

Q27026233-A9E7A027-A942-4E7D-B909-955A6B75E0BA

P356

Q27026233-1EE3EAB7-7811-4AD1-85AA-85F38B879C54

P407

Q27026233-17336C44-7893-498A-ADA7-62C191E825EA

P433

Q27026233-66D920B4-CC58-49D9-B86D-4965991B40EC

P478

Q27026233-A5127BDA-B5D9-4927-8C36-59F05C615E17

P577

Q27026233-328E30FF-21E3-40BD-A15C-6EC6893169F3

P5875

Q27026233-8B7E07A5-0A2C-4587-9632-58A435281B74

P698

Q27026233-B353A25E-101C-4590-8A5B-F8895CBE4D6A

P932

Q27026233-0D1F491D-725C-4BE4-B346-2A5AAA1554BE

P356

P1433

ACS Chemical Neuroscience

P1476

ACS chemical neuroscience molecule spotlight on Suvorexant

@en

P2093

Corey R. Hopkins

http://www.w3.org/2001/XMLSchema#string

P2860

The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity

Discovery of the dual orexin receptor antagonist [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the treatment of insomnia.

Insomnia and the performance of US workers: results from the America insomnia survey.

Prevalence, associated risks, and treatment patterns of insomnia.

P304

647-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/CN300086A

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

231614454

http://www.w3.org/2001/XMLSchema#string

P698

23024835

http://www.w3.org/2001/XMLSchema#string

P932

3447389

http://www.w3.org/2001/XMLSchema#string